Boditech Med Inc. (KOSDAQ:206640)
South Korea
· Delayed Price · Currency is KRW Boditech Med Statistics
Total Valuation
Boditech Med has a market cap or net worth of KRW 317.49 billion. The enterprise value is 277.78 billion.
| Market Cap | 317.49B |
| Enterprise Value | 277.78B |
Important Dates
The next estimated earnings date is Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | Mar 31, 2025 |
Share Statistics
Boditech Med has 21.79 million shares outstanding. The number of shares has decreased by -0.32% in one year.
| Current Share Class | 21.79M |
| Shares Outstanding | 21.79M |
| Shares Change (YoY) | -0.32% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 39.23% |
| Owned by Institutions (%) | 1.76% |
| Float | 13.12M |
Valuation Ratios
The trailing PE ratio is 11.45 and the forward PE ratio is 9.03.
| PE Ratio | 11.45 |
| Forward PE | 9.03 |
| PS Ratio | 2.20 |
| PB Ratio | 1.40 |
| P/TBV Ratio | 1.51 |
| P/FCF Ratio | 18.89 |
| P/OCF Ratio | 11.56 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.53, with an EV/FCF ratio of 16.53.
| EV / Earnings | 9.97 |
| EV / Sales | 1.93 |
| EV / EBITDA | 7.53 |
| EV / EBIT | 9.88 |
| EV / FCF | 16.53 |
Financial Position
The company has a current ratio of 4.91, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.91 |
| Quick Ratio | 3.31 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.22 |
| Debt / FCF | 0.48 |
| Interest Coverage | 113.00 |
Financial Efficiency
Return on equity (ROE) is 13.08% and return on invested capital (ROIC) is 7.99%.
| Return on Equity (ROE) | 13.08% |
| Return on Assets (ROA) | 7.22% |
| Return on Invested Capital (ROIC) | 7.99% |
| Return on Capital Employed (ROCE) | 12.26% |
| Revenue Per Employee | 279.93M |
| Profits Per Employee | 54.10M |
| Employee Count | 515 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 1.58 |
Taxes
In the past 12 months, Boditech Med has paid 5.28 billion in taxes.
| Income Tax | 5.28B |
| Effective Tax Rate | 15.89% |
Stock Price Statistics
The stock price has decreased by -10.94% in the last 52 weeks. The beta is 0.36, so Boditech Med's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -10.94% |
| 50-Day Moving Average | 16,186.60 |
| 200-Day Moving Average | 16,191.10 |
| Relative Strength Index (RSI) | 28.58 |
| Average Volume (20 Days) | 103,773 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Boditech Med had revenue of KRW 144.17 billion and earned 27.86 billion in profits. Earnings per share was 1,272.37.
| Revenue | 144.17B |
| Gross Profit | 85.16B |
| Operating Income | 28.31B |
| Pretax Income | 33.21B |
| Net Income | 27.86B |
| EBITDA | 37.05B |
| EBIT | 28.31B |
| Earnings Per Share (EPS) | 1,272.37 |
Balance Sheet
The company has 60.19 billion in cash and 8.02 billion in debt, giving a net cash position of 52.17 billion or 2,394.14 per share.
| Cash & Cash Equivalents | 60.19B |
| Total Debt | 8.02B |
| Net Cash | 52.17B |
| Net Cash Per Share | 2,394.14 |
| Equity (Book Value) | 226.77B |
| Book Value Per Share | 9,838.19 |
| Working Capital | 109.61B |
Cash Flow
In the last 12 months, operating cash flow was 27.47 billion and capital expenditures -10.66 billion, giving a free cash flow of 16.81 billion.
| Operating Cash Flow | 27.47B |
| Capital Expenditures | -10.66B |
| Free Cash Flow | 16.81B |
| FCF Per Share | 771.26 |
Margins
Gross margin is 59.07%, with operating and profit margins of 19.64% and 19.33%.
| Gross Margin | 59.07% |
| Operating Margin | 19.64% |
| Pretax Margin | 23.04% |
| Profit Margin | 19.33% |
| EBITDA Margin | 25.70% |
| EBIT Margin | 19.64% |
| FCF Margin | 11.66% |
Dividends & Yields
This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 1.01%.
| Dividend Per Share | 150.00 |
| Dividend Yield | 1.01% |
| Dividend Growth (YoY) | -25.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 15.77% |
| Buyback Yield | 0.32% |
| Shareholder Yield | 1.33% |
| Earnings Yield | 8.78% |
| FCF Yield | 5.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 5, 2017. It was a forward split with a ratio of 1.1.
| Last Split Date | Apr 5, 2017 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
Boditech Med has an Altman Z-Score of 9.17 and a Piotroski F-Score of 5.
| Altman Z-Score | 9.17 |
| Piotroski F-Score | 5 |